Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for AOP2014 in low-risk polycythemia vera patients, detailing its benefit/risk profile.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AOP2014

Snippet

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED